BiotechTube
Home/MygoGenesis/Michael Adams
MA

Michael Adams

VP Business Development

MygoGenesis

Therapeutic Areas

Regenerative MedicineOncologyCardiovascularNeurologyDiabetes

MygoGenesis Pipeline

DrugIndicationPhase
Mygotic Platform TherapeuticsCardiac/Neural/Pancreatic tissue repair, Cancer vaccinesPre-clinical
HematoGenesis™Production of Type O Negative bloodResearch
MyCellSafe™Autologous cell banking for future medical useDevelopment
AmeboGenesis™Sustainable production of amebocytes for LAL endotoxin testingDevelopment

Leadership Team at MygoGenesis

DK
Daniel Kilbank
Founder & Chief Scientific Officer
DZ
Deborah Zimmerman, RN
President & CEO
JO
Jeanne O’Connell, MD
Scientific & Medical Director
AS
Art Sagoskin, MD, FACOG
Chief Scientific Development Officer
MS
Marc Solomon
Chief Financial Officer
View full MygoGenesis profile